| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
47,312 |
47,312 |
47,312 |
47,312 |
| Total Sell Value |
$657,637 |
$657,637 |
$657,637 |
$657,637 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Erck Stanley C |
President and CEO |
• • – |
2020-09-28 |
4 |
OE |
$5.95 |
$297,500 |
D/D |
50,000 |
74,606 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
25,658 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$233,812 |
D/D |
(2,103) |
50,658 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$27,461 |
D/D |
(247) |
52,761 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$176,120 |
D/D |
29,600 |
53,008 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
21,510 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$148,750 |
D/D |
25,000 |
46,510 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-09-26 |
4 |
D |
$113.56 |
$276,405 |
D/D |
(2,434) |
24,606 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
27,040 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$2,116,645 |
D/D |
(18,639) |
21,510 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,588 |
40,149 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$1,943,807 |
D/D |
(17,117) |
23,408 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,438 |
25,117 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$1,912,805 |
D/D |
(16,844) |
18,304 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,873 |
20,223 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2020-08-18 |
4 |
S |
$150.44 |
$1,579,620 |
D/D |
(10,500) |
321,979 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2020-08-18 |
4 |
OE |
$27.60 |
$325,700 |
D/D |
10,500 |
332,479 |
|
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2020-08-18 |
4 |
S |
$146.00 |
$1,168,000 |
D/D |
(8,000) |
9,951 |
|
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2020-08-18 |
4 |
OE |
$27.60 |
$220,800 |
D/D |
8,000 |
17,951 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-08-18 |
4 |
S |
$142.85 |
$6,366,182 |
D/D |
(42,788) |
5,087 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-08-18 |
4 |
OE |
$27.00 |
$2,179,986 |
D/D |
42,788 |
47,875 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-08-18 |
4 |
S |
$143.92 |
$6,673,982 |
D/D |
(46,242) |
275 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-08-18 |
4 |
OE |
$27.00 |
$2,488,613 |
D/D |
46,242 |
46,517 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-08-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,528 |
311 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-08-18 |
4 |
S |
$143.94 |
$8,119,860 |
D/D |
(55,921) |
1,839 |
|
- |
|
453 Records found
|
|
Page 13 of 19 |
|
|
